| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sang-hyun Baik, Heung Sik Yoon, Sang Eun Kim, Sang Hee Ki. Extraversion and striatal dopaminergic receptor availability in young adults: an [18F]fallypride PET study. Neuroreport. vol 23. issue 4. 2012-10-18. PMID:22257904. |
we investigated whether dopaminergic receptor availability in the striatum was directly associated with individual differences in extraversion using the high-affinity radiotracer [¹⁸f]fallypride and pet. |
2012-10-18 |
2023-08-12 |
human |
| Sang-hyun Baik, Heung Sik Yoon, Sang Eun Kim, Sang Hee Ki. Extraversion and striatal dopaminergic receptor availability in young adults: an [18F]fallypride PET study. Neuroreport. vol 23. issue 4. 2012-10-18. PMID:22257904. |
both region of interest and voxel-based whole-brain analyses showed that extraversion was significantly correlated with dopaminergic receptor availability in the striatum bilaterally. |
2012-10-18 |
2023-08-12 |
human |
| Yu-bing Dai, Xin-jie Tan, Wan-fu Wu, Margaret Warner, Jan-Åke Gustafsso. Liver X receptor β protects dopaminergic neurons in a mouse model of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. vol 109. issue 32. 2012-10-15. PMID:22826221. |
administration of the lxr agonist gw3965 to mptp-treated wt mice protected against loss of dopaminergic neurons and of dopaminergic fibers projecting to the striatum, and resulted in fewer activated microglia and astroglia. |
2012-10-15 |
2023-08-12 |
mouse |
| Pierre Berthet, Jeanette Hellgren-Kotaleski, Anders Lansne. Action selection performance of a reconfigurable basal ganglia inspired model with Hebbian-Bayesian Go-NoGo connectivity. Frontiers in behavioral neuroscience. vol 6. 2012-10-15. PMID:23060764. |
the dopaminergic signal to striatum, the input stage of the bg, has been commonly described as coding a reward prediction error (rpe), i.e., the difference between the predicted and actual reward. |
2012-10-15 |
2023-08-12 |
monkey |
| Vanessa Franco, Robert S Turne. Testing the contributions of striatal dopamine loss to the genesis of parkinsonian signs. Neurobiology of disease. vol 47. issue 1. 2012-10-12. PMID:22498034. |
the diverse and independently-varying signs of parkinson's disease (pd) are often attributed to one simple mechanism: degeneration of the dopaminergic innervation of the posterolateral striatum. |
2012-10-12 |
2023-08-12 |
monkey |
| Jinming Zhang, Xiaojun Zhang, Yungang Li, Jiahe Tia. Simple, rapid and reliable preparation of [¹¹C]-(+)-α-DTBZ of high quality for routine applications. Molecules (Basel, Switzerland). vol 17. issue 6. 2012-10-09. PMID:22728363. |
[¹¹c]-(+)-α-dtbz has been used as a marker of dopaminergic terminal densities in human striatum and expressed in islet beta cells in the pancreas. |
2012-10-09 |
2023-08-12 |
human |
| Hong Yuan, Li-Wu Liang, Zheng-Jing Chen, Hui-Ru Ji, Mei-Kang Wang, Hai-Ying Zhang, Cao Li, Jian-Yang X. R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat. Neuroscience bulletin. vol 22. issue 6. 2012-10-02. PMID:17690718. |
objective the aim of the present study was not only to assess the retrograde degenerative changes in the dopaminergic neurons of the substantia nigra (sn) and ventral tegmental area (vta) after injection of 6-hydroxydopamine (6-ohda) into the striatum, but also to use this 6-ohda model of parkinson's disease to explore the possible neuroprotective effect of r-apomorphine (r-apo). |
2012-10-02 |
2023-08-12 |
rat |
| C Fernández, K De La Cuétara, O Castellanos, O González, N Nunez, L Alvarez, R Macías, A Torres, R Pernas, J Soto, H Molina, W Sole. Brain aging and neurotransplantation. I. Nigral cell suspension graft to aged rodent striatum and motor disabilities. Archives of gerontology and geriatrics. vol 19 Suppl 1. 2012-10-02. PMID:18649843. |
deficient rats were divided in two groups: one group received dissociated fetal dopaminergic cells from ventral mesencephalon (e12-e14) to striatum, whereas the other group having the same level of impairment, was followed without any graft and served as age-matched controls. |
2012-10-02 |
2023-08-12 |
rat |
| B Berger, J Nguyen-Legros, A M Thierr. Demonstration of horseradish peroxidase and fluorescent catecholamines in the same neuron. Neuroscience letters. vol 9. issue 4. 2012-10-02. PMID:19605235. |
after hrp injection into the striatum or into the nucleus accumbens of the rat, both fluorescent dopaminergic neurons labelled with hrp and non-fluorescent neurons labelled with hrp were observed in the substantia nigra or in the ventral tegmental area, respectively. |
2012-10-02 |
2023-08-12 |
rat |
| U Havemann, K Kuschinsk. Neurochemical aspects of the opioid-induced 'catatonia'. Neurochemistry international. vol 4. issue 4. 2012-10-02. PMID:20487869. |
part of this dopaminergic activation might be, in addition, due to actions on opioid receptors located on dopaminergic nerve endings within the striatum (localization i) or the nucleus accumbens. |
2012-10-02 |
2023-08-12 |
Not clear |
| K Kuriyama, E Kurihar. Correlation between rotational behaviors and neurochemical changes associated with damage of rat striatum: Analysis using unilateral microinjection of kainic acid. Neurochemistry international. vol 4. issue 6. 2012-10-02. PMID:20487910. |
these results suggest that the increase of dopamine release from dopaminergic neurons in the striatum may be involved in the occurrence of contralateral turning behaviors observed shortly after the striatal kainic acid treatment. |
2012-10-02 |
2023-08-12 |
rat |
| M I Rudolph, L Arqueros, G Busto. l-Glutamic acid, a neuromodulator of dopaminergic transmission in the rat corpus striatum. Neurochemistry international. vol 5. issue 4. 2012-10-02. PMID:20487976. |
l-glutamic acid, a neuromodulator of dopaminergic transmission in the rat corpus striatum. |
2012-10-02 |
2023-08-12 |
rat |
| M I Rudolph, L Arqueros, G Busto. l-Glutamic acid, a neuromodulator of dopaminergic transmission in the rat corpus striatum. Neurochemistry international. vol 5. issue 4. 2012-10-02. PMID:20487976. |
the findings reported have led us to propose that l-glutamic acid could play a role as a neuromodulator of dopaminergic transmission in the rat corpus striatum. |
2012-10-02 |
2023-08-12 |
rat |
| P Frey, M Lis, D M Cowar. Neurotensin concentrations in rat striatum and nucleus accumbens: Further studies of their regulation. Neurochemistry international. vol 12. issue 1. 2012-10-02. PMID:20501200. |
the possible influence of cholinergic and dopaminergic mechanisms on neurotensin-containing neurones was examined at two different levels; nucleus accumbens and striatum in the rat brain. |
2012-10-02 |
2023-08-12 |
rat |
| P Liberini, E Nisoli, C Missale, M Memo, M Buonamici, A Rossi, P F Span. Differential effect of acute reserpine administration on D-1 and D-2 dopaminergic receptor density and function in rat striatum. Neurochemistry international. vol 14. issue 1. 2012-10-02. PMID:20504400. |
differential effect of acute reserpine administration on d-1 and d-2 dopaminergic receptor density and function in rat striatum. |
2012-10-02 |
2023-08-12 |
rat |
| T Kuriyama, J Taguchi, K Kuriyam. Functional alterations in striatal cholinergic and striato-nigral gabaergic neurons following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration. Neurochemistry international. vol 16. issue 3. 2012-10-02. PMID:20504575. |
neurochemical changes in cholinergic neurons in the striatum and ?-aminobutyric acid (gaba)ergic neurons in the midbrain, especially in the basal ganglia, have been examined following the intraperitoneal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp), which is known to cause behavioral changes resembling those in parkinson's disease due to the destruction of nigro-striatal dopaminergic neurons. |
2012-10-02 |
2023-08-12 |
mouse |
| T Kuriyama, J Taguchi, K Kuriyam. Functional alterations in striatal cholinergic and striato-nigral gabaergic neurons following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration. Neurochemistry international. vol 16. issue 3. 2012-10-02. PMID:20504575. |
furthermore, it was found that mptp treatment induced an increase of the gaba(a) receptor-benzodiazepine receptor-chloride channel complex in the substantia nigra in addition to that of dopaminergic d(2) receptor in the striatum. |
2012-10-02 |
2023-08-12 |
mouse |
| J Q Wang, J F McGint. Glutamate-dopamine interactions mediate the effects of psychostimulant drugs. Addiction biology. vol 4. issue 2. 2012-10-02. PMID:20575780. |
the striatum, a major central nervous system structure modulating movement, is enriched with glutamatergic and dopaminergic innervation. |
2012-10-02 |
2023-08-12 |
Not clear |
| Xin Zhao, Quan Li, Lei Zhao, Xiaoping P. Proteome analysis of substantia nigra and striatal tissue in the mouse MPTP model of Parkinson's disease. Proteomics. Clinical applications. vol 1. issue 12. 2012-10-02. PMID:21136655. |
the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) replicates many of the pathological hallmarks of parkinson's disease (pd) in mice via selective destruction of dopamine neurons of the substantia nigra and striatum. |
2012-10-02 |
2023-08-12 |
mouse |
| S H Lee, M Maral Mouradia. Transcription mechanisms for dopamine receptor genes. Methods in molecular medicine. vol 62. 2012-10-02. PMID:21318777. |
the d(1a) dopamine receptor is one of two dopamine receptors abundantly expressed in the striatum (9), suggesting that it has a critical role in transmitting the nigrostriatal dopaminergic signal resulting in normal motor function. |
2012-10-02 |
2023-08-12 |
human |